Fusion Antibodies (LSE:FAB) Days Sales Outstanding : 140.16 (As of Sep. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Fusion Antibodies Days Sales Outstanding?

Fusion Antibodies's average Accounts Receivable for the six months ended in Sep. 2023 was £0.42 Mil. Fusion Antibodies's Revenue for the six months ended in Sep. 2023 was £0.54 Mil. Hence, Fusion Antibodies's Days Sales Outstanding for the six months ended in Sep. 2023 was 140.16.

The historical rank and industry rank for Fusion Antibodies's Days Sales Outstanding or its related term are showing as below:

LSE:FAB' s Days Sales Outstanding Range Over the Past 10 Years
Min: 49.65 Med: 68.26 Max: 157.42
Current: 157.42

During the past 9 years, Fusion Antibodies's highest Days Sales Outstanding was 157.42. The lowest was 49.65. And the median was 68.26.

LSE:FAB's Days Sales Outstanding is ranked worse than
78.34% of 891 companies
in the Biotechnology industry
Industry Median: 71.97 vs LSE:FAB: 157.42

Fusion Antibodies's Days Sales Outstanding increased from Sep. 2022 (97.37) to Sep. 2023 (140.16).

Fusion Antibodies Days Sales Outstanding Historical Data

The historical data trend for Fusion Antibodies's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fusion Antibodies Days Sales Outstanding Chart

Fusion Antibodies Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Days Sales Outstanding

Get a 7-Day Free Trial

103.46

59.37

49.65

52.02

71.47

Fusion Antibodies Semi-Annual Data
	Mar15	Mar16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Days Sales Outstanding	Get a 7-Day Free Trial											86.24	96.40	97.37	138.19	140.16

Competitive Comparison of Fusion Antibodies's Days Sales Outstanding

For the Biotechnology subindustry, Fusion Antibodies's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Fusion Antibodies's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Fusion Antibodies's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Fusion Antibodies's Days Sales Outstanding falls into.

Fusion Antibodies Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Fusion Antibodies's Days Sales Outstanding for the fiscal year that ended in Mar. 2023 is calculated as

	Days Sales Outstanding (A: Mar. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Mar. 2022 )	+	Accounts Receivable (A: Mar. 2023 ))	/	count )	/	Revenue (A: Mar. 2023 )	*	Days in Period
=	( (0.776	+	0.36)	/	2 )	/	2.901	*	365
=	0.568					/	2.901	*	365
=	71.47

Fusion Antibodies's Days Sales Outstanding for the quarter that ended in Sep. 2023 is calculated as:

	Days Sales Outstanding (Q: Sep. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Mar. 2023 )	+	Accounts Receivable (A: Sep. 2023 ))	/	count )	/	Revenue (A: Sep. 2023 )	*	Days in Period
=	( (0.36	+	0.471)	/	2 )	/	0.541	*	365 / 2
=	0.4155					/	0.541	*	365 / 2
=	140.16

Fusion Antibodies (LSE:FAB) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Fusion Antibodies Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Fusion Antibodies's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Fusion Antibodies (LSE:FAB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Fusion Antibodies PLC (LSE:FAB) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

1 Springbank Road, Springbank Industrial Estate, Dunmurry, Belfast, GBR, BT17 0QL

Website

https://www.fusionantibodies.com

Fusion Antibodies PLC offers a range of antibody engineering services for all stages of therapeutic and diagnostic antibody development. It is engaged in the research, development, and manufacturing of recombinant proteins, particularly in the areas of cancer and infectious diseases. Its services include antibody sequencing, antibody humanization, stable cell line development, monoclonal antibody production, and transient protein expression. Geographically company generates the majority of its revenue from North America.

Fusion Antibodies (LSE:FAB) Headlines

From GuruFocus

626 Financial, LLC Buys 3, Sells 2 in 3rd Quarter

By GuruFocus Research GuruFocus Editor • 10-21-2022